Molecular markers and determinants of prostate cancer metastasis

Journal of Cellular Physiology

Volumn 189, Issue 3, 2001, Pages 245-256

  Gopalkrishnan, Rahul V ^a   Kang, Dong Chul ^a   Fisher, Paul B ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER GROWTH; CANCER INVASION; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; HUMAN; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035164169     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10023     Document Type: Review

References (131)

1. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer
2. Low frequency of microsatellite instability in hereditary prostate cancer
3. Induction of KAI-1 expression in metastatic cancer cells by phorbol esters
4. Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma
5. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
6. Better gel resolution and longer cDNAs increase the precision of differential display
7. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression
8. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
9. Metastasis-related genes in prostate cancer
10. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - Preliminary findings
11. Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer
12. Thymosin beta 15 expression in tumor cell lines with varying metastatic potential
13. Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR
14. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin
15. Molecular themes in oncogenesis
16. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
17. Laser capture microdissection: Molecular analysis of tissue
18. Web-based tissue microarray image data analysis: Initial validation testing through prostate cancer Gleason grading
19. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis
20. Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study
21. Development of human prostate cancer models for chemoprevention and experimental therapeutics studies
22. Prostate cancer. An overview of an increasing dilemma
23. Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation
24. Hereditary prostate cancer
25. The emerging roles of cell surface heparan sulfate proteoglycans
26. Cell surface receptors
27. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
28. Prostate cancer - Biology of metastasis and its clinical implications
29. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
30. Molecular advances in prostate cancer
31. Microarray-based expression profiling in prostate tumors
32. Molecular genetics of prostate cancer
33. Tumor heterogeneity and the biology of cancer invasion and metastasis
34. The biology of cancer metastasis or, 'you cannot fix it if you do not know how it works'
35. Cancer metastasis
36. The biology of cancer metastasis and implications for therapy
37. Search for genes that suppress cancer metastasis
38. Enhancement of viral transformation and expression of the transformed phenotype by tumor promoters
39. A new technology for preparing monoclonal antibodies to molecules expressed on the surface
40. Etiology, epidemiology and pathology of prostate cancer
41. Biology of metastasis
42. Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers
43. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepategenesis
44. Stromal mesenchymal progenitor cells
45. The role of tissue microdissection in cancer research
46. Translational infidelity and human cancer: Role of the PTI-1 oncogene
47. Molecular characterization of prostate carcinoma tumor antigen-1, PCTA- 1, a human galectin-8 related gene
48. Workgroup 3: Transgenic and reconstitution models of prostate cancer
49. Cancer statistics 2000
50. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
51. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptesis
52. Differential display PCR: A new age in nutrition investigation
53. The prostate: Development and physiology
54. Sibling risks in cancer: Clues to recessive or X-linked genes
55. DNA microarrays for analysis of gene expression
56. Autochthonous mouse models for prostate cancer: Past, present and future
57. Metastasis suppressor genes for prostate cancer
58. RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes
59. Reciprocal subtraction differential RNA display: An efficient and rapid procedure for isolating differentially expressed gene sequences
60. Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH
61. Current status of linkage studies in hereditary prostate cancer
62. Mechanisms of cancer metastasis
63. Studies on human hyperplastic prostates maintained in organ culture
64. Molecular and cellular biology of prostate cancer
65. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone
66. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
67. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells
68. Recent advances in differential display
69. Current status of thymosin research: Evidence for the existence of a family of thymic factors that control T-cell maturation
70. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression
71. Identification of a novel microsatellite marker tightly linked to the KAI-1 gene for predicting prostate cancer progression
72. The CD34+Thy1+ cell population: Are they all stem cells
73. Evidence of an X-linked or recessive genetic component to prostate cancer risk
74. Chemical homeosis in cell growth: A molecular target at the cell surface
75. Construction of human-rodent hybrid cells containing single transferable fragments of human chromosome 10p
76. Small actin-binding proteins: The beta-thymosin family
77. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
78. Genetic alterations in hormone-refractory recurrent prostate carcinomas
79. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity
80. Genetics of prostate cancer: Too many loci, too few genes
81. Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice
82. Caveolae and caveolins
83. Genetic linkage analysis of prostate cancer families to Xq27-28
84. Androgen ablation - 50 years later
85. The pathogenesis of cancer metastasis
86. Prostate cancer and other xenografts from cells in peripheral blood of patients
87. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma
88. Reconstitution of the glycosylphosphatidylinositol-anchored protein Thy-1: Interaction with membrane phospholipids and galactosylceramide
89. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
90. Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer
91. Genome and genetic resources from the Cancer Genome Anatomy Project
92. Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidase
93. Defining the biologic role of genes that regulate prostate cancer metastasis
94. Identification of hypoxia-responsive messengers expressed in human microvascular endothelial cells using differential display RT-PCR
95. A new cancer genome anatomy project web resource for the community
96. Bone metastases: Improving the therapeutic index
97. Crowded little caves: Structure and function of caveolae
98. Mouse models of prostate cancer
99. Surface-epitope masking: A strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface
100. Identification of a novel human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display
101. Cell surface galactosyltransferase: Current issues
102. Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization
103. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
104. Workgroup 2: Human xenograft models of prostate cancer
105. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection
106. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family
107. Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene
108. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes
109. PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis
110. Laser capture microdissection of single cells from complex tissues
111. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples
112. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor
113. The Dunning model
114. Metastasis-related genes in prostate cancer: The role of caveolin-1
115. Loss of p53 function leads to metastasis in ras + myc-initiated mouse prostate cancer
116. Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease
117. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: Detection of numerical and structural chromosome aberrations
118. Use of nude mouse xenograft models in prostate cancer research
119. Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis
120. Analysing uncharted transcriptomes with SAGE
121. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer
122. What defines a useful marker of metastasis in human cancer
123. New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents
124. Genomewide scan for prostate cancer-aggressiveness loci
125. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines
126. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
127. Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes
128. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
129. Prostate cancer metastasis-suppressor genes: A current perspective
130. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17
131. Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1beta-converting enzyme inhibition